跳至主要内容
临床试验/ACTRN12610000973011
ACTRN12610000973011已完成未知

A randomised controlled trial to determine whether the administration of prophylactic high flow nasal oxygen improves pulmonary function in patients following cardiac surgery

Auckland City Hospital0 个研究点目标入组 300 人开始时间: 2010年11月11日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients will be screened and are eligible for inclusion in the study if all of the following criteria are met:
  • : over 18 years of age
  • : informed consent obtained
  • : scheduled for cardiac surgery involving full median sternotomy.
  • : cardiac surgery = CABG; valvular; CABG + valve
  • : patient not normally on NIV at home
  • : patient is extubated prior to 1000 hours day after surgery

排除标准

  • Patients will be excluded if any of the following exist:
  • : contraindication for NHF use e.g. severe nasal septal defect
  • : need for timely NIV e.g. CPAP to treat obstructive sleep apnoea
  • : previous recruitment into this study
  • : patient is likely to be intubated and mechanically ventilated for >24 hours
  • following operation
  • : post-operatively patient is still ventilated at 1000 post-op day 1

研究者

相似试验